Delivered & milestones achieved Archives - Avillion Life Sciences

23Feb
2018

Avillion notes that Pfizer Received a Positive CHMP Opinion for BOSULIF®

16Feb
2018

Avillion Advances Co-development Programme with Merck

20Dec
2017

Avillion announces US approval of Pfizer’s BOSULIF®

06Jun
2017

BFORE study presented in oral session at ASCO

06Dec
2016

Pfizer and Avillion Announce Positive Top-Line Results for Phase 3 BFORE Study of BOSULIF for First-Line Treatment of Philadelphia Chromosome Positive Chronic Myeloid Leukemia